Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eiajCfbwoceZiyxNGazY

January 22, 2013News for medical technology professionals

  Top Story 
 
  • Zimmer gets FDA OK for knee replacement guidance system
    The FDA has given Zimmer 510(k) clearance to market its iASSIST Knee system, which is used to guide surgeons during joint replacement procedures. The device, which consists of disposable electronic pod components, helps doctors validate the alignment of knee implants via an electronic display at the surgical site. RTT News (1/17) LinkedInFacebookTwitterEmail this Story
GI Dynamics Initiates ENDO Pivotal Trial
GI Dynamics (Lexington, MA) reported that it has initiated its U.S. multicenter pivotal clinical trial of EndoBarrier, the ENDO trial, for the treatment of patients who have uncontrolled Type 2 diabetes and are obese - thus moving one step closer to getting the device approved in the U.S. market. Find out the details.

  Business & Market Trends 
  • Life Technologies mulls putting itself up for sale, sources say
    Life Technologies reportedly is in talks with health care firms and private equity groups about a possible sale of the company. The Carlsbad, Calif.-based firm, which specializes in laboratory materials and DNA-sequencing tools, is said to have employed Deutsche Bank and Moelis & Co. to help with its strategic review. Bloomberg Businessweek (1/19) LinkedInFacebookTwitterEmail this Story
  • Brainsway eyes distribution deal for depression system
    Brainsway is in talks with various medical device companies to market its Deep TMS System used for depression treatment in the U.S., with a deal likely to be reached this quarter, CEO Uzi Sofer said. The device gained regulatory approval this month in Canada and the U.S. for treating patients who can't tolerate or don't respond to antidepressants. Bloomberg Businessweek (1/21) LinkedInFacebookTwitterEmail this Story
  International Developments 
  • EU approves Integra's diabetes wound management system
    Integra LifeSciences has earned CE mark approval in Europe to market a device used to help patients with diabetes manage their chronic wounds. The Integra Flowable Wound Matrix system, which works by filling deep soft tissue or tunneling wounds, could help reduce the risk of amputation in patients with diabetes. RTT News (1/18) LinkedInFacebookTwitterEmail this Story
  Science & Health 
  • Clinical trial begins for Covidien's stroke therapy device
    Covidien has begun patient enrollment in a clinical study to compare its Solitaire FR revascularization system with using an intravenous tissue plasminogen activator alone to treat patients with acute ischemic stroke. As many as 800 patients from 60 clinical sites across the globe will be enrolled in the study. The Solitaire FR is used to restore blood flow to the brain. MassDevice.com (Boston) (1/17) LinkedInFacebookTwitterEmail this Story
  Emerging Technologies 
The Buzz(CORPORATE ANNOUNCEMENTS)

Interested in learning more about advertising with SmartBrief? Click here for detailed industry information and media kits. 

  Industry Service Providers 
  • Precision signs deal with hospital GPO for patient ID tools
    Premier has awarded a three-year contract to Precision Dynamics-St. John, maker of the Smart Band RFID system, a barcode identification wristband. The deal calls for Precision to supply the hospital group purchasing organization with its labels, wristbands and other patient identification tools. Health Tech Zone (1/21) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
AdvaMed News 
  • Medical Device Reimbursement Workshop
    Tuesday, Feb. 26 – Wednesday, Feb. 27
    Sheraton Crystal City, Arlington, Va.
    Learn from medical device reimbursement experts what new legislative and regulatory changes apply to the area of reimbursement; the key reimbursement issues for medical technology; how Medicare coverage is determined at the national and local levels; the role of MEDCAC; why technology assessments are important; how clinical trial results impact payers; what you need to do to keep up on new reimbursement developments relevant to your products; how to maintain a nimble, dynamic, effective, ongoing reimbursement program; what to do when reimbursement is denied; drill-down coding systems; differences in inpatient and outpatient payment systems; physician fee schedules and product design; how to negotiate CMS coverage; how to plan for the new health care reform landscape deal with comparative effectiveness; and how to manage international reimbursement. Visit MTLI online for more information. LinkedInFacebookTwitterEmail this Story
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom

 
Position TitleCompany NameLocation
Product Support Specialist IVArthroCare CorporationAustin, TX
Director of Clinical AffairsEndologixIrvine, CA
Sr. Clinical Research AssociateEndologix, Inc.Irvine, CA
Quality Systems ManagerRoche DiagnosticsIndianapolis, IN
Regulatory Affairs Clinical SpecialistMindray DS USA, Inc.Mahwah, NJ
Area Reimbursement Manager (Central U.S. or Northeast U.S.)SI-BONE, IncMultiple Locations, United States
Program Director, Regulatory AffairsJohnson & JohnsonFremont, CA
Click here to view more job listings.

  SmartQuote 
It ain't what they call you, it's what you answer to."
--W.C. Fields,
American comedian, actor and writer


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information